Changeflow GovPing Healthcare & Life Sciences MBIOSEQ Trademark Application Published for Opp...
Routine Notice Added Consultation

MBIOSEQ Trademark Application Published for Opposition

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The USPTO has published the trademark application for MBIOSEQ for opposition. The application covers reagents, assays, software, and instruments related to medical diagnostics, molecular biology, and laboratory testing. The filing date was November 18, 2025.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'MBIOSEQ' for a 30-day opposition period. The application, filed on November 18, 2025, seeks to register trademarks for a range of goods and services including diagnostic and chemical reagents for medical, veterinary, and research purposes, software for laboratory apparatus and bioinformatics analysis, laboratory apparatus, medical instruments, and services related to the identification and characterization of biological substances.

This publication signifies that the trademark has passed initial examination and is now open for challenges from third parties who believe they may be harmed by the registration. Companies operating in the pharmaceutical, biotechnology, and medical device sectors should monitor this application if they have similar existing trademarks or are planning to launch products under a similar name. No immediate compliance actions are required for entities other than potential opposers, but awareness of this pending registration is advisable for strategic branding and intellectual property management.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

MBIOSEQ

Published for Opposition TM79440054 Kind: published Mar 26, 2026

Abstract

Reagents and assays for medical purposes; diagnostic reagents and assays for medical use; chemical reagents for molecular biology, for medical or veterinary use; chemical reagents and assays for use in medical and veterinary testing, for detecting genetic mutations.; Downloadable and recorded computer software for laboratory apparatus, other than for medical use; downloadable and recorded computer software for processing, evaluating and displaying measurement data from a laboratory apparatus; downloadable and recorded software for bioinformatics analysis, genomic data interpretation, and drug resistance profiling; laboratory apparatus, other than for medical use; laboratory apparatus, other than for medical use, for the collection, sequencing, application, and transfer of microbial and non-microbial preparations.; Medical instruments; instruments for carrying-out diagnostic tests for medical purposes; laboratory instruments for medical use; laboratory instruments for medical use for collection, sequencing, application, and transfer of microbial and non-microbial preparations; medical instruments for use in molecular diagnostics.; Reagents and assays for research purposes; diagnostic reagents and assays for scientific use; chemical reagents and assays for molecular biology, other than for medical or veterinary use; chemical reagents and assays for use in genetic research, for detecting genetic mutations.; Natural science and technical services for identifying and characterizing substances, in particular measurement of biological samples and evaluating measurement data of biological samples; design and development of computer software for use in molecular diagnostics.

Filing Date

2025-11-18

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor
Document ID
TM79440054

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 5112 Software & Technology
Activity scope
Trademark Registration Medical Diagnostics Molecular Biology
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Biotechnology Medical Devices

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!